China Food and Drug Administration (CFDA) recently released the 2014 Annual Report for National Adverse Drug Reaction Monitoring. In 2014, the national adverse drug reaction monitoring network received 1.328 million adverse drug reaction/event (ADR/ADE) case reports, up 0.8% than the previous year, including 341 thousand new and serious ADR/ADE cases (25.7% of the total). ADR reporting coverage rate reached 94.4% at county level; 991 ADR cases, on average, were reported per million people. The Annual Report indicates that China’s ADR reporting coverage was increased, the ability to discover and collect ADR information was enhanced, and the public’s drug safety awareness was further improved.